Thursday, April 03, 2014
328A Russell Senate Office Building 2 Constitution Ave NE Washington, DC 20002Hearing Co-Chairs: Chairman Dennis C. Shea and Vice-Chairman William Reinsch
8:30 – 8:45 am Co-chairs’ remarks: Chairman Dennis C. Shea and Vice-Chairman William Reinsch
8:45 – 9:30 am Administration Panel
- Dr. Christopher J. Hickey, Country Director, U.S. Food and Drug Administration, People's Republic of China (Testimony)
9:30 am –9:45 am: Break
9:45 am – 11:15 am Panel I: Policy Challenges in China’s Healthcare Sector
- Dr. Karen Eggleston, Faculty Director, Asia Health Policy Program, Stanford University, Stanford, CA (Testimony)
- Dr. Yanzhong Huang, Senior Fellow for Global Health Policy, Council on Foreign Relations, New York, NY (Testimony)
- Xiaoqing Lu Boynton, Director, Albright Stonebridge Group, Washington, DC (Testimony)
11:15 am –11:30 am Break
11:30 am – 1:00 pm Panel II: Market Access for U.S. Medical Goods and Services in China
- Benjamin Shobert, Managing Director, Rubicon Strategy Group, Seattle, WA; Senior Associate, National Bureau of Asian Research, Washington, DC (Testimony)
- Rod Hunter, Senior Vice President, International Affairs, PhRMA, Washington, DC
- Ralph Ives, Executive Vice President, Global Strategy and Analysis, AdvaMed, Washington, DC (Testimony)
1:00 – 2:00 pm Lunch break
2:00 pm – 3:30 pm Panel III: The Safety of Medical Product Imports from China into the United States
- Allan Coukell, Senior Director, Drugs and Medical Devices, The Pew Charitable Trusts, Washington, DC (Testimony)
- Charles Bell, Programs Director, Consumers Union, Yonkers, NY (Testimony)
- Dr. Ginger Zhe Jin, Professor of Economics, University of Maryland, College Park, MD (Testimony)
- Dr. Roger Bate, Visiting Fellow, American Enterprise Institute, Washington, DC (Written Testimony)
3:30 pm Adjourn
Transcript